Vestmark Advisory Solutions’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.05M	Buy	550,144 +106,217	+24%	+$1.35M	0.08%	262
2025 Q4	$3.99M	Buy	443,927 +146,361	+49%	+$2.01M	0.05%	357
2025 Q3	$5.14M	Sell	297,566 -340,776	-53%	-$4.2M	0.1%	206
2025 Q2	$5.99M	Buy	638,342 +326,460	+105%	+$2.68M	0.09%	173
2025 Q1	$2.22M	Sell	311,882 -63,409	-17%	-$640K	0.06%	312
2024 Q4	$5.41M	Buy	375,291 +47,045	+14%	+$734K	0.19%	111
2024 Q3	$6.75M	Sell	328,246 -27,079	-8%	-$624K	0.25%	81
2024 Q2	$7.95M	Sell	355,325 -65,072	-15%	-$1.55M	0.33%	63
2024 Q1	$11.6M	Buy	420,397 +154,416	+58%	+$4.29M	0.5%	42
2023 Q4	$8.11M	Buy	+265,981	New	+$7.64M	0.41%	53